[The therapy of myelodysplastic syndromes].

[Myelodysplastic syndromes].

Epigenetics of myelodysplastic syndromes.

Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes.

Pathobiology of myelodysplastic syndromes.

Infection in the myelodysplastic syndromes.

Therapy with human recombinant erythropoietin in patients with myelodysplastic syndromes.

Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive.

Iron overload and chelation therapy in myelodysplastic syndromes.

Low-dose etoposide: a potential therapy for myelodysplastic syndromes.

Myelodysplastic syndromes, version 2.2015.

Thymopentin in the treatment of myelodysplastic syndromes.

Clofarabine in the treatment of myelodysplastic syndromes.

Molecular pathogenesis of myelodysplastic syndromes.

Danazol treatment of myelodysplastic syndromes.

Complications and treatment of the myelodysplastic syndromes.

Molecular basis of myelodysplastic syndromes.

Trisomy 14q in myelodysplastic syndromes.

Clonal evolution in myelodysplastic syndromes.

The GNAS1 gene in myelodysplastic syndromes (MDS).

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Jumping translocations in myelodysplastic syndromes.

Prognostic models in myelodysplastic syndromes.

Intensive chemotherapy in myelodysplastic syndromes.

The "n-1" model for myelodysplastic syndromes.

Suggest Documents

[Myelodysplastic syndromes].

Epigenetics of myelodysplastic syndromes.

Clinical outcome after failure of hypomethylating therapy for myelodysplastic syndromes.

Pathobiology of myelodysplastic syndromes.

Infection in the myelodysplastic syndromes.

Therapy with human recombinant erythropoietin in patients with myelodysplastic syndromes.

Immunosuppressive Therapy in Myelodysplastic Syndromes Is Still Alive.

Iron overload and chelation therapy in myelodysplastic syndromes.

Low-dose etoposide: a potential therapy for myelodysplastic syndromes.

Myelodysplastic syndromes, version 2.2015.

Thymopentin in the treatment of myelodysplastic syndromes.

Clofarabine in the treatment of myelodysplastic syndromes.

Molecular pathogenesis of myelodysplastic syndromes.

Danazol treatment of myelodysplastic syndromes.

Complications and treatment of the myelodysplastic syndromes.

Molecular basis of myelodysplastic syndromes.

Trisomy 14q in myelodysplastic syndromes.

Clonal evolution in myelodysplastic syndromes.

The GNAS1 gene in myelodysplastic syndromes (MDS).

[Myelodysplastic syndromes. The epidemiological and etiological aspects].

Jumping translocations in myelodysplastic syndromes.

Prognostic models in myelodysplastic syndromes.

Intensive chemotherapy in myelodysplastic syndromes.

The "n-1" model for myelodysplastic syndromes.

[The therapy of myelodysplastic syndromes].

Recommend Documents

Follow Us